 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: CFO Rebecca Byam Acquires 5,000 Shares of HCW Biologics Inc

Insider Buying: CFO Rebecca Byam Acquires 10,000 Shares of HCW Biologics Inc

Company will provide an update for clinical development and intellectual property programs, Including recent achievements and expected milestones in the next 12 monthsMIRAMAR, Fla., Sept. 06, 2023...

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11   13, 2023

MIRAMAR, Fla., Aug. 11, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the Company or HCW Biologics ) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...

HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCW Biologics (HCWB Research Report) and Arrowhead... Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on HCW Biologics (HCWB Research Report) and Arrowhead ...

Analysts Offer Insights on Healthcare Companies: HCW Biologics (HCWB) and Arrowhead Pharmaceuticals (ARWR)

HCW Biologics GAAP EPS of -$0.12 beats by $0.04

HCW Biologics (NASDAQ:HCWB  Get Rating) and GRI Bio (NASDAQ:GRI  Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, earnings, dividends, analyst recommendations, ...

HCW Biologics (NASDAQ:HCWB) and GRI Bio (NASDAQ:GRI) Financial Review

NextCure (NASDAQ:NXTC Get Rating) and HCW Biologics (NASDAQ:HCWB Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ...

HCW Biologics (NASDAQ:HCWB) versus NextCure (NASDAQ:NXTC) Head-To-Head Review

HCW Biologics Inc. (NASDAQ:HCWB  Get Rating) was the target of a significant decline in short interest in May. As of May 31st, there was short interest totalling 13,000 shares, a decline of 13.3% from the May 15th total of 15,000 shares. Based on an average daily volume of 19,500 shares, the ...

Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Declines By 13.3%

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Watchers	1,079
52-Wk Low	$1.08
52-Wk High	$2.74

Market Cap	$70.78M
Volume (M)	56.00
52-Wk High	$2.74
52-Wk Low	$1.08

Current Price	$1.97
Prev Close	$2.05
Open	$2.15
Dividend Yield	0.00%
50-Day Moving Average	$2.04
Beta	0.00
Avg. Volume	5,622.39
PE Ratio	-3.78

52-Week High	$2.74
52-Week Low	$1.08
Market Capitalization	$70.78M
EPS	-$0.5215
Price to Book	2.48
Revenue Per Employee	$86,709.89
Enterprise Value/EBITDA	-3.58

HCWB HCW Biologics Inc

About

Feed

News

Earnings

Fundamentals